ATE318902T1 - Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung - Google Patents

Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung

Info

Publication number
ATE318902T1
ATE318902T1 AT94905480T AT94905480T ATE318902T1 AT E318902 T1 ATE318902 T1 AT E318902T1 AT 94905480 T AT94905480 T AT 94905480T AT 94905480 T AT94905480 T AT 94905480T AT E318902 T1 ATE318902 T1 AT E318902T1
Authority
AT
Austria
Prior art keywords
peptides
appendixes
allergenic proteins
dog skin
activity
Prior art date
Application number
AT94905480T
Other languages
English (en)
Inventor
Jay P Morgenstern
Andrzej Konieczny
Christine B Bizinkauskas
Andrew W Brauer
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Application granted granted Critical
Publication of ATE318902T1 publication Critical patent/ATE318902T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94905480T 1992-12-31 1993-12-30 Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung ATE318902T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99971292A 1992-12-31 1992-12-31
US15654993A 1993-11-22 1993-11-22

Publications (1)

Publication Number Publication Date
ATE318902T1 true ATE318902T1 (de) 2006-03-15

Family

ID=26853298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94905480T ATE318902T1 (de) 1992-12-31 1993-12-30 Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung

Country Status (10)

Country Link
US (7) US5939283A (de)
EP (2) EP1277764A3 (de)
JP (1) JPH08507436A (de)
AT (1) ATE318902T1 (de)
AU (1) AU5957694A (de)
CA (1) CA2152818A1 (de)
DE (1) DE69333985T2 (de)
DK (1) DK0677105T3 (de)
ES (1) ES2260756T3 (de)
WO (1) WO1994016068A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0677105T3 (da) * 1992-12-31 2006-07-10 Immulogic Pharma Corp Allergifremkaldende proteiner og peptider fra hundeskæl og anvendelser derfor
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
GB2349463B (en) 1996-03-21 2001-01-10 Circassia Ltd Cryptic peptides and method for their identification
US7025964B1 (en) 1996-11-13 2006-04-11 Meiji Dairies Corporation Peptide-based immunotherapeutic agent
WO1999039211A1 (en) * 1998-01-30 1999-08-05 Sampson Hugh A Prognostic allergy or inflammation test
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US6478274B1 (en) * 1999-05-10 2002-11-12 Innovative Office Products, Inc. Arm apparatus for mounting electronic devices
EP1272213B1 (de) 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbielles wirkstoffabgabesystem
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2429372A1 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
WO2005019255A1 (en) 2003-08-25 2005-03-03 Pieris Proteolab Ag Muteins of tear lipocalin
WO2006075253A2 (en) * 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
US9216212B2 (en) 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
US8450594B2 (en) * 2007-07-26 2013-05-28 Guardian Industries Corp. Method of making an antireflective silica coating, resulting product and photovoltaic device comprising same
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
US8580270B2 (en) 2008-09-30 2013-11-12 University Of Massachusetts Respiratory synctial virus (RSV) sequences for protein expression and vaccines
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
US20140155469A1 (en) 2011-04-19 2014-06-05 The Research Foundation Of State University Of New York Adeno-associated-virus rep sequences, vectors and viruses
EP2894478B1 (de) * 2014-01-13 2017-01-11 Biomedical International R + D GmbH Verfahren und Mittel zur Diagnose und Behandlung einer Allergie durch Lipocalinspiegel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
DE3942871A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
DK0677105T3 (da) 1992-12-31 2006-07-10 Immulogic Pharma Corp Allergifremkaldende proteiner og peptider fra hundeskæl og anvendelser derfor
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins

Also Published As

Publication number Publication date
US20070202132A1 (en) 2007-08-30
WO1994016068A2 (en) 1994-07-21
EP0677105B1 (de) 2006-03-01
US6489118B2 (en) 2002-12-03
DE69333985D1 (de) 2006-04-27
AU5957694A (en) 1994-08-15
US20060057641A1 (en) 2006-03-16
ES2260756T3 (es) 2006-11-01
US7166291B2 (en) 2007-01-23
EP1277764A2 (de) 2003-01-22
US5843672A (en) 1998-12-01
US5939283A (en) 1999-08-17
WO1994016068A3 (en) 1994-10-27
EP1277764A3 (de) 2003-01-29
EP0677105A1 (de) 1995-10-18
US7666441B2 (en) 2010-02-23
US5891716A (en) 1999-04-06
US7026128B2 (en) 2006-04-11
US20030049691A1 (en) 2003-03-13
DE69333985T2 (de) 2006-11-23
DK0677105T3 (da) 2006-07-10
CA2152818A1 (en) 1994-07-21
JPH08507436A (ja) 1996-08-13
US20020012963A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DE69333985D1 (de) Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE69635088T2 (de) NEUTROKIN alpha
ATE87655T1 (de) Markierer der t-zelle aktivierung.
DE68929151D1 (de) Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
ATE449965T1 (de) Diagnostisches und therapeutisches epitop
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
EP0690914A4 (de) Allergenes protein und peptide der hausstaubmilbe
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE79403T1 (de) Herstellung von thrombin-inhibitoren.
ATE353964T1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
DE69528379D1 (de) Paraoxonase aus serum
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
ATE119914T1 (de) Peptide, deren verwendung als immuno- suppressanten und verfahren zu deren herstellung.
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
AU650649B2 (en) Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration
DE69434665D1 (de) Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren
ATE141645T1 (de) In vitro-behandlung von fusionsproteinen

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0677105

Country of ref document: EP

EEIH Change in the person of patent owner